United States

Synthetic Biologics, Intrexon collaborate on infectious diseases

Wednesday, August 8, 2012 01:55 PM

Synthetic Biologics, an Ann Arbor, Mich.-based developer of synthetic biologics and innovative medicines for unmet medical needs, and Intrexon, a Germantown, Md.-based synthetic biology company that provides control over cellular function, have entered into a second worldwide exclusive channel collaboration through which Synthetic Biologics intends to develop and commercialize a series of monoclonal antibody (mAb) therapies for the treatment of certain infectious diseases not adequately addressed by existing therapies.

More... »

Amneal to invest $120M to grow U.S. operations, create 500 jobs

Wednesday, August 8, 2012 11:21 AM

Amneal Pharmaceuticals, a manufacturer of generic pharmaceuticals based in Hauppauge, N.Y., is investing $120 million in physical plant capital expenditures from 2012-2014 to significantly grow its operations at three of its six current U.S. R&D, manufacturing and distribution facilities.

More... »

Mission Search to provide commissioning services for Sensus Healthcare

Wednesday, August 8, 2012 10:01 AM

Mission Search, a Tampa, Fla.-based healthcare search and staffing organization, is has joined forces with Sensus Healthcare, a Boca Raton, Fla.-based company focused on skin cancers, to provide commissioning services to Sensus’ clientele.

More... »

FDA approves Zaltrap for metastatic colorectal cancer

Monday, August 6, 2012 12:51 PM

The FDA has approved Sanofi-Aventis’ Zaltrap (ziv-aflibercept) for use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.

More... »

Markey, House democrats introduce bill to protect human subjects in clinical trials

Monday, August 6, 2012 11:59 AM

Rep. Edward J. Markey (D-Mass.), senior member of the Energy and Commerce Committee, has introduced H.R. 6272, the Trial and Experimental Studies Transparency (TEST) Act of 2012 to close clinical trial loopholes and bring certainty and transparency to life-saving research studies.

More... »

UTEP science program receives $4.2M grant from NIH

Friday, August 3, 2012 11:43 AM

The Research Initiative for Scientific Enhancement (RISE) program at The University of Texas, El Paso, has been awarded a five-year grant from the National Institutes of Health (NIH) totaling more than $4.2 million , funding student research training initiatives until 2017.

More... »

RxAlly adds Mike Groh as CIO

Thursday, August 2, 2012 03:33 PM

RxAlly, an alliance of more than 22,000 pharmacies nationwide, has appointed Michael J. Groh, PharmD, as chief information officer.

More... »

Hologic completes acquisition of Gen-Probe

Thursday, August 2, 2012 02:17 PM

Hologic, a developer, manufacturer and supplier of diagnostic products, medical imaging systems and surgical products, has completed its acquisition of Gen-Probe, a developer of nucleic acid tests, for approximately $3.8 billion. Gen-Probe is now a wholly-owned subsidiary of Hologic.

More... »

Theorem relocates headquarters to accommodate growth

Thursday, August 2, 2012 12:24 PM

Theorem Clinical Research, a midsize CRO that provides core clinical research and development services, has relocated its headquarters 1.5 miles from the original site in King of Prussia, Penn., where the company has been located for the past 10 years.

More... »

New York Genome Center launches innovation center

Thursday, August 2, 2012 11:42 AM

New York Genome Center (NYGC), a non-profit engaged in a cooperative effort to transform medical research and clinical care, has launched its innovation center, which will provide access to new sequencing technologies and foster collaboration among NYGC’s institutional founding members (IFMs) and technology collaborators.

More... »